Program

7:00 AM-8:00 AM

Poster Session B: Patient Safety and Science of Quality

With complimentary continental breakfast

8:00 AM-9:30 AM

Welcome and General Session 4: Patient-Centered Care—Hearing the Patient's Voice to Assess and Promote High-Quality Cancer Care
David Rice, PhD, RN, NP—Co-Chair

City of Hope

Larissa Temple, MD—Co-Chair
University of Rochester

 

Monika K. Krzyzanowska, MD, MPH, FRCPC
Princess Margaret Cancer Centre
Welcome of the Day

 

Neeraj K. Arora, PhD
PCORI
Can You Hear Me Now? Importance of Assessing Patients' Cancer Care Experiences

 

Ethan M. Basch, MD, MSc, FASCO
The University of North Carolina at Chapel Hill
Bringing the Patient Voice into Care Delivery and Quality Assessment

 

Gwendolyn P. Quinn, PhD
H. Lee Moffitt Cancer & Research Institute
Suppressed Voices: Are We Listening to the Perspectives of Underserved Patients With Cancer and Survivors

 

Kate Niehaus, MBA
Patient and Family Advisory Council for Quality, Memorial Sloan Kettering Cancer Center
Using Patient and Family Advisory Councils as a Mechanism for the Patient's Voice

 

Panel Question and Answer

9:30 AM-10:00 AM

Break

10:00 AM-11:30 AM

General Session 5: Using Electronic Medical Records to Collect Data, Report on Aggregate Experiences, and Adapt to Changing Knowledge
Natalie R. Dickson, MD—Co-Chair

Tennessee Oncology

Jennifer Malin, MD, PhD—Co-Chair
United Healthcare

 

Michael J. Hassett, MD, MPH
Dana-Farber Cancer Institute
How Many Clicks Are Too Many: Usability Considerations in Oncology EHRs

 

Amy Abernethy, MD, PhD
Flatiron Health
Quality Reporting: Challenges in Aggregating Data from the EHR

 

Mark A. Sitarik, MD
US Oncology
Better and Smarter: Capturing New Genomic Information into the EHR

 

Panel Question and Answer

11:30 AM-1:00 PM

Poster Session B: Patient Safety and Science of Quality (Continued)

With complimentary boxed lunch

11:45 AM-12:30 PM

Poster Walks

Learn more about Poster Walks

 

Steven Clauser, PhD, MPA 

Patient-Centered Outcomes Research Institute 

 

Ari-Nareg Meguerditchian, MD, FRCS

McGill University Health Centre

1:00 PM-2:30 PM

Oral Abstract Session B

Carolyn B. Hendricks, MD—Co-Chair

Maryland Oncology Hematology

Craig Earle, MD, MSc—Co-Chair

Ontario Institute for Cancer Research

 

Abstract 36: Near miss or safety incident in patients treated with radiotherapy: What are the contributing factors?

First author: Greg Judy

Abstract 37: Significant and sustained reduction in chemotherapy errors though improvement science.

First author: Brian Weiss

Abstract 51: Reviewing systemic treatment regimens to reduce unintentional errors.

First author: Andrea Crespo

 

Discussion: Joseph O. Jacobson, MD, MSc, FASCO

Dana-Farber Cancer Institute

 

 

Abstract 52: Reducing overuse of colony-stimulating factors without compromising patient safety: Evidence from a decision-support enabled utilization management in patients with lung cancer receiving chemotherapy.

First author: Gboyega Adeboyeje

Abstract 3: Cost and survival analysis before and after implementation of Dana-Farber Clinical Pathways for Patients with Stage IV Non-Small Cell Lung Cancer.

First author: Yichen Zhang

 

Discussion: Thomas J. Smith, MD, FACP, FASCO, FAAHPM

Johns Hopkins Medicine

 

Panel Question and Answer

2:30 PM-3:00 PM

Break

3:00 PM-4:30 PM

General Session 6: Successful Models for Integrating Quality and Patient Safety Into Health Care Organizations

Joseph O. Jacobson, MD, MSc, FASCO—Chair
Dana-Farber Cancer Institute

 

Brent James, MD, MStat
Intermountain Healthcare
Advancing Quality: Intermountain Health, Salt Lake City

 

Panel Question and Answer